J&J Reports Q2 Sales Of $25.31 Billion - JNJ News | RalliesJ&J Reports Q2 Sales Of $25.31 Billion
J
JNJ• J&J posts stronger-than-expected Q2 sales and EPS
- J&J Q2 DARZALEX worldwide sales: $4.21 billion
- J&J Q2 sales: $25.31 billion versus IBES estimate $25.05 billion
- J&J Q2 adjusted EPS: $2.90 versus IBES estimate $2.85
- J&J Q2 STELARA worldwide sales: $740 million; TREMFYA worldwide sales: $2.05 billion
- J&J outlook FY adjusted EPS: $11.60–$11.75 versus IBES estimate $11.59
- J&J said it is on track to meet its 2026 target of more than $100 billion in annual revenue
BCTX
•
